Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of CAD 216.16 billion. The enterprise value is 284.33 billion.

Market Cap	216.16B
Enterprise Value	284.33B

Important Dates

The last earnings date was Tuesday, February 4, 2025.

Earnings Date	Feb 4, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.16%
Shares Change (QoQ)	-0.04%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	5.66B

Valuation Ratios

The trailing PE ratio is 18.71.

PE Ratio	18.71
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.01, with an EV/FCF ratio of 20.09.

EV / Earnings	24.61
EV / Sales	3.10
EV / EBITDA	8.01
EV / EBIT	11.99
EV / FCF	20.09

Financial Position

The company has a current ratio of 1.17, with a Debt / Equity ratio of 0.76.

Current Ratio	1.17
Quick Ratio	0.82
Debt / Equity	0.76
Debt / EBITDA	2.75
Debt / FCF	6.85
Interest Coverage	5.28

Financial Efficiency

Return on equity (ROE) is 9.06% and return on invested capital (ROIC) is 6.37%.

Return on Equity (ROE)	9.06%
Return on Assets (ROA)	4.64%
Return on Invested Capital (ROIC)	6.37%
Return on Capital Employed (ROCE)	9.58%
Revenue Per Employee	1.13M
Profits Per Employee	142,658
Employee Count	88,000
Asset Turnover	0.29
Inventory Turnover	1.56

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.80% in the last 52 weeks. The beta is 0.57, so Pfizer's price volatility has been lower than the market average.

Beta (5Y)	0.57
52-Week Price Change	-2.80%
50-Day Moving Average	12.20
200-Day Moving Average	12.94
Relative Strength Index (RSI)	47.89
Average Volume (20 Days)	79,527

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.22

Income Statement

In the last 12 months, Pfizer had revenue of CAD 91.55 billion and earned 11.56 billion in profits. Earnings per share was 2.03.

Revenue	91.55B
Gross Profit	67.92B
Operating Income	23.49B
Pretax Income	11.54B
Net Income	11.56B
EBITDA	33.56B
EBIT	23.49B
Earnings Per Share (EPS)	2.03

Full Income Statement

Balance Sheet

The company has 29.46 billion in cash and 97.00 billion in debt, giving a net cash position of -67.54 billion.

Cash & Cash Equivalents	29.46B
Total Debt	97.00B
Net Cash	-67.54B
Net Cash Per Share	n/a
Equity (Book Value)	127.33B
Book Value Per Share	22.39
Working Capital	10.59B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 18.34 billion and capital expenditures -4.19 billion, giving a free cash flow of 14.15 billion.

Operating Cash Flow	18.34B
Capital Expenditures	-4.19B
Free Cash Flow	14.15B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 74.19%, with operating and profit margins of 25.66% and 12.62%.

Gross Margin	74.19%
Operating Margin	25.66%
Pretax Margin	12.61%
Profit Margin	12.62%
EBITDA Margin	36.65%
EBIT Margin	25.66%
FCF Margin	15.46%

Dividends & Yields

Pfizer does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	118.44%
Buyback Yield	0.16%
Shareholder Yield	0.16%
Earnings Yield	5.35%
FCF Yield	6.55%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pfizer has an Altman Z-Score of 2.12. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.12
Piotroski F-Score	n/a